COVID Misinformation a Roadblock to Curbing Pandemic

November 09, 2020

The World Health Organization calls the spread of false information about the coronavirus (COVID-19) an "infodemic," and the results are broadly visible across society. The refusal of some people to wear a mask or socially distance, or self-quarantine when exposed to the virus, is often motivated by false information or conspiracy theories that are popular on social media.

So what are public health officials to do?

In a pair of newly published studies, University of Delaware researchers shed new light on the stigma, stereotypes and conspiracy theories that have spread alongside the novel coronavirus.

Understanding the impact of misinformation "is important for identifying potential barriers to public health efforts" to combat the virus, said Valerie Earnshaw, associate professor in UD's Department of Human Development and Family Sciences and lead author on both studies.

"Evidence suggests that people are more likely to believe conspiracy theories when they feel anxious, powerless, and unable to control their outcomes, as well as in times of crisis and when faced with large-scale events with serious consequences," she said. "Pandemics such as COVID-19 are powerful contexts wherein individuals may turn to conspiracy theories in an attempt to restore feelings of safety and control."

Ultimately, the more prominent the misinformation, the more difficult it will be for communities to bring the pandemic under control.

The first study, "Anticipated Stigma, Stereotypes, and COVID-19 Testing," which appeared in the journal Stigma and Health, suggests that stereotypes and anticipated stigma may be barriers to COVID-19 testing efforts. The results, Earnshaw said, are very similar to previous studies about HIV and Ebola stigma.

"We know from studies on mental illness and HIV that stigma will keep people from getting tested," said Earnshaw. "And stereotypes are one way that people experience stigma. Stereotypes are how stigma gets into our heads and shapes our views. Stereotypes help people feel safe. Stereotypes help people believe that those who get COVID, or HIV, are unlike them or doing the wrong thing. Stereotypes can sometimes give people a false security blanket."

Participants who anticipated more stigma, and those who endorsed more harmful stereotypes, reported that they would be less likely to get tested for COVID-19. By contrast, participants who demonstrated greater knowledge of COVID-19 reported that they would be more likely to get tested.

The second study, "COVID-19 conspiracy beliefs, health behaviors, and policy support," which appeared in the journal Translational Behavioral Medicine, found that one-third of participants believed in one or more conspiracies about COVID-19, and the results suggest that belief in conspiracy theories makes a person less likely to support public health policies designed to slow the spread of the virus. Participants who believed in conspiracy theories said that they were less likely to get vaccinated and trusted public health experts less.

The results of both studies were derived from an online survey of 845 U.S. adults that was conducted in April 2020. The survey was posted to Amazon Mechanical Turk, a crowdsourcing marketplace that researchers use to "collect rapid, high-quality data for psychological studies," said Earnshaw.

Despite the prevalence of misinformation, both studies suggest that people trust their personal doctor, regardless of their conspiracy beliefs. In the first study, most participants agreed that they would get tested if ordered by their doctor. In the second study, over 90% said they trusted information about COVID-19 from their doctor.

"Medical doctors are highly trusted sources of medical information," said Earnshaw. "Doctors can play a leading role in combating misinformation because even people who believe conspiracy theories still believe information about COVID from their doctors."
-end-


University of Delaware

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.